-
PurposeExpresses Human Dnase1L3 in mammalian cells along with DsRed
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 98845 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepIRES2-DsRed2
-
Backbone manufacturerClontech
- Backbone size w/o insert (bp) 5300
- Total vector size (bp) 6200
-
Modifications to backboneNone
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameDnase1L3
-
Alt nameDnase gamma
-
SpeciesH. sapiens (human)
-
Insert Size (bp)914
-
Mutationlong isoform, wild type
-
GenBank IDDQ896097.2
-
Entrez GeneDNASE1L3 (a.k.a. DHP2, DNAS1L3, LSD, SLEB16)
- Promoter CMV
-
Tag
/ Fusion Protein
- IRES DsRed
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site BamHI (not destroyed)
- 5′ sequencing primer CMV forward (Genewiz Universal)
- 3′ sequencing primer IRES- (custom) (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byDnase1L3 cloned by PCR initially from Open Biosystems
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Dnase1L3 pIRES-DsRed was a gift from Peter Keyel (Addgene plasmid # 98845 ; http://n2t.net/addgene:98845 ; RRID:Addgene_98845) -
For your References section:
Dnase1L3 Regulates Inflammasome-Dependent Cytokine Secretion. Shi G, Abbott KN, Wu W, Salter RD, Keyel PA. Front Immunol. 2017 May 8;8:522. doi: 10.3389/fimmu.2017.00522. eCollection 2017. 10.3389/fimmu.2017.00522 PubMed 28533778